First Citizens Bank & Trust Co. Has $5.49 Million Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

First Citizens Bank & Trust Co. grew its stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 77.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 127,696 shares of the company’s stock after purchasing an additional 55,643 shares during the period. First Citizens Bank & Trust Co. owned about 2.63% of SPDR S&P Pharmaceuticals ETF worth $5,490,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in XPH. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 36.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock valued at $197,000 after purchasing an additional 1,182 shares in the last quarter. AlphaMark Advisors LLC boosted its stake in shares of SPDR S&P Pharmaceuticals ETF by 5.9% in the 3rd quarter. AlphaMark Advisors LLC now owns 6,225 shares of the company’s stock valued at $276,000 after purchasing an additional 348 shares in the last quarter. Stifel Financial Corp acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $337,000. CX Institutional acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter valued at approximately $438,000. Finally, Rockport Wealth LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter valued at approximately $1,813,000.

SPDR S&P Pharmaceuticals ETF Price Performance

NYSEARCA:XPH opened at $45.00 on Friday. The firm’s 50 day simple moving average is $44.39 and its 200 day simple moving average is $44.24. SPDR S&P Pharmaceuticals ETF has a one year low of $38.88 and a one year high of $48.76. The company has a market cap of $218.25 million, a PE ratio of 14.39 and a beta of 0.87.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.